Topcon Healthcare acquired RetInSight, an Austria-based company that develops AI-driven software for eye care professionals, ...

Q1 2025 Earnings Call Transcript May 7, 2025 EyePoint Pharmaceuticals, Inc. reports earnings inline with expectations. Reported EPS is $-0.65 EPS, expectations were $-0.65. Operator: Good morning. My ...

Machine learning algorithms enhance retinopathy of prematurity screening using smartphone images, expanding access in ...

Scientists say they have determined that low blood sugar, or hypoglycemia, may promote a breakdown of the blood-retinal barrier, an important boundary that regulates the flow of nutrients, waste and ...

New research reveals that hypoglycemia may worsen diabetic retinopathy by breaking down the blood-retinal barrier.

The effectivity of orthokeratology lenses may be dependent upon a number of nonsynonymous variants in retinal disease-related gene sets.

If it's your first time using a retinoid, look for retinol creams with ingredients like hyaluronic acid, squalane and ...

Phase II trial results indicated that treatment with the firm's antisense oligonucleotide led to stable or improved best-corrected visual acuity.

Low blood sugar contributes to eye damage and vision loss in diabetic retinopathy; an experimental drug may help treat the ...

Apellis reported a net loss of $92.2 million for the first quarter of 2025 compared to a net loss of $66.4 million for the same period in 2024. Cash. As of March 31, 2025, Apellis had $358.4 million ...

Can we maintain the progress of in-car technology but dial down the presence of screens? Or are display-averse shoppers stuck ...

In a new National Institutes of Health-funded study led by scientists at the Wilmer Eye Institute, Johns Hopkins Medicine ...